Profhilo Treatments in London

Results from Profhilo typically last for around six months following a full course of two sessions. The improvement in skin hydration, elasticity, and firmness develops progressively after each injection and continues as collagen and elastin production increases over time. Individual results vary depending on age, skin type, lifestyle, and the degree of skin laxity present at the time of treatment. A maintenance session every six months is generally recommended to preserve the overall improvement in skin quality.

Profhilo is not a filler. While both treatments contain hyaluronic acid and are delivered by injection, they work in fundamentally different ways. Dermal fillers are injected directly to add volume or reshape a specific area, whereas Profhilo disperses evenly under the skin to hydrate tissue and stimulate collagen and elastin production. Profhilo does not alter facial structure or correct volume deficit; its clinical purpose is to improve skin quality and reduce signs of ageing caused by dehydration and laxity.

The standard protocol involves two sessions, spaced 4 weeks apart. This initial course is designed to build a sustained improvement in skin hydration, elasticity, and collagen and elastin production. Most patients see meaningful results following both sessions combined. After completing the initial course, a single maintenance session every six months is typically sufficient to sustain the overall improvement in skin quality. The exact treatment plan is confirmed during the consultation, based on individual clinical assessment.

Discomfort during Profhilo injections is generally mild to moderate. The treatment involves a limited number of injection points on each side of the face, and topical anaesthetic cream can be applied beforehand to reduce sensitivity. Most patients tolerate the procedure well, with any discomfort resolving immediately after each injection point is completed. Individual pain tolerance, skin sensitivity, and the specific treatment area will all influence the experience. Concerns about comfort are always discussed during the consultation and planning stage.

Profhilo is associated with minimal downtime. Small bumps or mild swelling at the injection sites are common in the hours after the treatment and typically settle within 24 to 48 hours. Some patients experience minor bruising, which resolves within a few days. Most people return to normal activities the same day, though strenuous exercise, heat exposure, and makeup at the treated area are generally avoided for the first 24 hours following treatment.

Profhilo is ideal for patients experiencing early-to-moderate skin laxity, reduced elasticity, loss of hydration, or generalised dullness. It is commonly used in patients from their mid-thirties onwards, though suitability depends on individual skin condition, medical history, and treatment goals rather than age alone. Profhilo can be used on the face and neck and is appropriate for those seeking improvement in overall skin quality without volumisation. Final suitability is always determined by clinical assessment at the consultation.

Visible improvement in skin hydration and radiance often begins within the first two to four weeks following the initial injection. The full effects of Profhilo become more apparent after the second treatment, typically at the 4-week mark, as collagen and elastin production continues to develop. Skin texture, tone, and firmness all improve progressively over the weeks that follow. The biological remodelling process means that results continue to evolve for several weeks after both sessions are complete.

Profhilo can be used alongside other injectable treatments or skin procedures, though the suitability of any combined protocol depends on individual anatomy, skin condition, and timing. Treatments like Profhilo that target hydration and elasticity are often complemented by procedures addressing volume loss or surface concerns that this skin booster alone does not resolve. Any combined approach is planned during the consultation to ensure that sequencing, product selection, and treatment intervals are clinically appropriate for each individual.